David E. Olson
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
David E. Olson is an American chemist and neuroscientist. He is a professor of chemistry, biochemistry and molecular medicine at the University of California, Davis, and is the founding director of the UC Davis Institute for Psychedelics and Neurotherapeutics. Olson is best known for his work investigating neuroplasticity promoting compounds, especially the potential of psychedelic drugs, including ketamine and serotonergic psychedelics, to alter brain structure and function. Olson also coined a term to refer to small molecules that are fast acting, durable neuroplasticity promoting compounds: psychoplastogens. Psychoplastogens are being developed to treat a wide variety of neuropsychiatric and neurodegenerative diseases, including depression, PTSD, and substance use disorders, among many others. He researched non-hallucinogenic psychoplastogens, which decouple therapeutic neuroplasticity from hallucinogenic effects. Key examples of these silent plastogens developed by his team include Zalsupindole and Tabernanthalog.
David E. Olson is an American chemist and neuroscientist. He is a professor of chemistry, biochemistry and molecular medicine at the University of California, Davis, and is the founding director of the UC Davis Institute for Psychedelics and Neurotherapeutics. Olson is best known for his work investigating neuroplasticity promoting compounds, especially the potential of psychedelic drugs, including ketamine and serotonergic psychedelics, to alter brain structure and function. Olson also coined a term to refer to small molecules that are fast acting, durable neuroplasticity promoting compounds: psychoplastogens. Psychoplastogens are being developed to treat a wide variety of neuropsychiatric and neurodegenerative diseases, including depression, PTSD, and substance use disorders, among many others. He researched non-hallucinogenic psychoplastogens, which decouple therapeutic neuroplasticity from hallucinogenic effects. Key examples of these silent plastogens developed by his team include Zalsupindole and Tabernanthalog. ==See also== List of psychedelic chemists
Text derived from https://en.wikipedia.org/w/index.php?oldid=1372872728 under CC BY-SA 4.0; modifications have been made.